Clinical Trial Update: A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix [Phase 4]

View source ↗

Summary

Phase IV study assessing immunogenicity and safety of Menitorix in UK laboratory workers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaccination

Drugs mentioned

• Menitorix

Snippet

Sponsor: Public Health England | Conditions: Vaccination | Phase 4 | Status: COMPLETED